Gut microbiota modulating therapy for diabetes mellitus should be individualized

Area of Science:

• Endocrinology
• Microbiology
• Metabolic Diseases

Background:

• Emerging research highlights the gut microbiota's role in diabetes mellitus (DM) pathogenesis.
• Numerous animal studies suggest a link, but human data and mechanistic understanding remain limited.

Purpose of the Study:

• To critically evaluate recent findings on gut microbiota modulation for preventing and managing diabetes mellitus.
• To emphasize the need for mechanistic clarity and personalized therapeutic strategies.

Main Methods:

• Editorial commentary on two recent articles in the World Journal of Diabetes.
• Synthesis of existing literature on gut microbiota and diabetes mellitus.

Main Results:

• The gut microbiota's involvement in DM is suggested but not fully elucidated.
• Current interventions modifying gut microbiota for DM often lack long-term data and mechanistic insights.

Conclusions:

• Gut microbiota modification holds therapeutic potential for diabetes mellitus.
• Individual variability necessitates personalized, mechanistic-driven interventions for optimal outcomes.